Passage Bio, Inc.
PASG
$4.94
$0.091.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -7.26% | -24.35% | -20.46% | -25.96% | -17.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -29.89% | -37.30% | -33.78% | -32.10% | -29.18% |
| Operating Income | 29.89% | 37.30% | 33.78% | 32.10% | 29.18% |
| Income Before Tax | 36.48% | 40.63% | 29.71% | 34.21% | 25.75% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 36.48% | 40.63% | 29.71% | 34.21% | 25.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.48% | 40.63% | 29.71% | 34.21% | 25.75% |
| EBIT | 29.89% | 37.30% | 33.78% | 32.10% | 29.18% |
| EBITDA | 28.40% | 35.77% | 31.67% | 30.77% | 28.45% |
| EPS Basic | 37.19% | 41.22% | 32.34% | 38.54% | 33.35% |
| Normalized Basic EPS | 29.64% | 38.03% | 36.49% | 37.67% | 37.17% |
| EPS Diluted | 37.19% | 41.22% | 32.34% | 38.54% | 33.35% |
| Normalized Diluted EPS | 29.64% | 38.03% | 36.49% | 37.67% | 37.17% |
| Average Basic Shares Outstanding | 1.13% | 1.02% | 3.56% | 6.88% | 10.40% |
| Average Diluted Shares Outstanding | 1.13% | 1.02% | 3.56% | 6.88% | 10.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |